ATS projects 2Q revenue above analyst estimates

Recs

0

Heart valve maker ATS Medical Inc. on Monday forecast second-quarter revenue between $16.7 million and $16.9 million, above Wall Street expectations.

On average, analysts polled by Thomson Financial expect revenue of $15.7 million for the quarter ended June 28.

The company said its estimate represents about a 35 percent increase over year-ago revenue of $12.4 million.

ATS said its second-quarter revenue was buoyed by sales of its ATS CryoMaze surgical ablation device, which is used in operations where small portions of heart tissue are destroyed to stop abnormal heart rhythms, and strong sales of heart valve products.

The company expects new product launches to drive second-quarter sales of heart valve products up 10 percent year-over-year.

ATS Medical also said that with the recent negotiation of a two-year, $5 million revolving credit line with director Theodore C. Skokos, it doesn't believe it will need to raise additional capital to execute current growth plans.

ATS Medical will release second-quarter results on Aug. 4.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 679214, ~/articles/articlehandler.aspx, 12/5/2008 1:10:23 AM,

Sign up for FREE Motley Fool site access to keep reading:

“ATS projects 2Q revenue above analyst estimates”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Market Summary

S&P 500845.22 -2.93%
DJIA8,376.24 -2.51%
NASD1,445.56 -3.14%
Updated: 4:02:39 PM
Sponsored by:

Related Tickers

ATS Medical, Inc.

CAPS Rating 5/5 Stars

$2.21

-0.08 (-3.49%)

Outperform163

Underperform2

Rate This Stock